TY - JOUR
T1 - Corticosteroids
T2 - Triamcinolone, dexamethasone and fluocinolone
AU - Cáceres-Del-Carpio, Javier
AU - Costa, Rodrigo Donato
AU - Haider, Asghar
AU - Narayanan, Raja
AU - Kuppermann, Baruch D.
N1 - Publisher Copyright:
© 2016 S. Karger AG, Basel.
PY - 2015
Y1 - 2015
N2 - Steroids have been extensively used to treat macular edema due to diabetic retinopathy, venous occlusive disease, ocular inflammation and, to a lesser extent, also in some cases of choroidal neovascularization. The various intraocular steroids that have been employed include dexamethasone, triamcinolone and fluocinolone. During the past few years, new drug delivery methods for corticosteroids have been developed and are now part of our therapeutic armamentarium. This chapter provides a brief description of the pharmacology, efficacy and adverse effects associated with the use of steroids in various retinal diseases.
AB - Steroids have been extensively used to treat macular edema due to diabetic retinopathy, venous occlusive disease, ocular inflammation and, to a lesser extent, also in some cases of choroidal neovascularization. The various intraocular steroids that have been employed include dexamethasone, triamcinolone and fluocinolone. During the past few years, new drug delivery methods for corticosteroids have been developed and are now part of our therapeutic armamentarium. This chapter provides a brief description of the pharmacology, efficacy and adverse effects associated with the use of steroids in various retinal diseases.
UR - http://www.scopus.com/inward/record.url?scp=84947245889&partnerID=8YFLogxK
U2 - 10.1159/000431198
DO - 10.1159/000431198
M3 - Article
C2 - 26502207
AN - SCOPUS:84947245889
SN - 0250-3751
VL - 55
SP - 221
EP - 231
JO - Developments in Ophthalmology
JF - Developments in Ophthalmology
ER -